Detalles de la búsqueda
1.
Luteinizing hormone-releasing hormone agonists in the treatment of prostate cancer: a review of their discovery, development, and place in therapy.
Clin Ther
; 28(10): 1485-508, 2006 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-17157109
2.
The novel sequence-specific DNA cross-linking agent SJG-136 (NSC 694501) has potent and selective in vitro cytotoxicity in human B-cell chronic lymphocytic leukemia cells with evidence of a p53-independent mechanism of cell kill.
Cancer Res
; 64(18): 6750-5, 2004 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15374993
3.
A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma.
Neuro Oncol
; 5(2): 79-88, 2003 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-12672279
4.
Population pharmacokinetic/pharmacodynamic modeling of drug-induced adverse effects of a novel homocamptothecin analog, elomotecan (BN80927), in a Phase I dose finding study in patients with advanced solid tumors.
Cancer Chemother Pharmacol
; 70(2): 239-50, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22699813
5.
Steroid sulfatase: a new target for the endocrine therapy of breast cancer.
Oncologist
; 12(4): 370-4, 2007 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-17470679
Resultados
1 -
5
de 5
1
Próxima >
>>